DE60133287D1 - Tumorantigen - Google Patents

Tumorantigen

Info

Publication number: DE60133287D1
Authority: DE; Germany
Prior art keywords: tumor antigen; peptide; polynucleotide; tumor; hla
Prior art date: 2000-07-31
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60133287T

Other languages

English (en)

Other versions

DE60133287T2 (de

Inventor

Kyogo Itoh

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

BrightPath Biotherapeutics Co Ltd

Original Assignee

Green-Peptide Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-31

Filing date

2001-07-30

Publication date

2008-04-30

2001-07-30 Application filed by Green-Peptide Co Ltd filed Critical Green-Peptide Co Ltd

2008-04-30 Application granted granted Critical

2008-04-30 Publication of DE60133287D1 publication Critical patent/DE60133287D1/de

2009-03-26 Publication of DE60133287T2 publication Critical patent/DE60133287T2/de

2021-07-31 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/32—T-cell receptors [TCR]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
- A61K2239/50—Colon
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
- A61K2239/54—Pancreas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE60133287T 2000-07-31 2001-07-30 Tumorantigen Expired - Lifetime DE60133287T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000231814		2000-07-31
JP2000231814		2000-07-31
PCT/JP2001/006526 WO2002010369A1 (en)	2000-07-31	2001-07-30	Tumor antigen

Publications (2)

Publication Number	Publication Date
DE60133287D1 true DE60133287D1 (de)	2008-04-30
DE60133287T2 DE60133287T2 (de)	2009-03-26

Family

ID=18724591

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60133287T Expired - Lifetime DE60133287T2 (de)	2000-07-31	2001-07-30	Tumorantigen

Country Status (9)

Country	Link
US (6)	US7148326B2 (de)
EP (1)	EP1306431B1 (de)
JP (1)	JP4900884B2 (de)
AT (1)	ATE389668T1 (de)
AU (1)	AU2002227498A1 (de)
CA (1)	CA2417570C (de)
DE (1)	DE60133287T2 (de)
ES (1)	ES2304398T3 (de)
WO (1)	WO2002010369A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1473564A4 (de) *	2001-09-18	2008-12-10	Greenpeptide Co Ltd	Verfahren zum nachweis von zellimmunität und dessen anwendung auf arzneistoffe
WO2005073374A1 (ja) *	2004-01-29	2005-08-11	Dainippon Sumitomo Pharma Co., Ltd.	新規腫瘍抗原蛋白質及びその利用
US20080200088A1 (en) *	2007-02-21	2008-08-21	Chong Pyung An	Method for reducing interference fringes in a display device
EP2801367B1 (de)	2007-09-18	2017-04-19	Green Peptide Co., Ltd.	CTL-Induktorzusammensetzung
EP2123748A1 (de) *	2008-05-20	2009-11-25	Institut Pasteur	2'-5'-Oligoadenylat-Synthetase 3 zur Vorbeugung und Behandlung von positivgerichteten einsträngigen RNA-Virusinfektionen
BRPI1016204A2 (pt)	2009-04-22	2016-04-19	Merck Patent Gmbh	proteínas de fusão de anticorpos com sítios de ligação fcrn modificados
CN107412755A (zh)	2009-07-02	2017-12-01	Ith免疫治疗控股公司	基于外泌体的癌症治疗
KR20120137386A (ko)	2010-03-03	2012-12-20	고쿠리츠 다이가쿠 호진 교토 다이가쿠	위암 검출용 마커 및 위암 검출 방법
CA2821080C (en)	2010-12-14	2021-02-02	University Of Maryland, Baltimore	Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
EP2752666A4 (de) *	2011-08-29	2015-11-11	Toray Industries	Marker zum nachweis von kolorektalkarzinom oder speiseröhrenkrebs und verfahren zu seiner prüfung
WO2014041784A1 (en) *	2012-09-11	2014-03-20	Oncotherapy Science, Inc.	Ube2t peptides and vaccines containing the same
WO2014100615A1 (en)	2012-12-20	2014-06-26	Purdue Research Foundation	Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
US9701729B2 (en)	2013-03-08	2017-07-11	Taiho Pharmaceutical Co., Ltd.	Peptide having 5 linked CTL epitopes
JP6211093B2 (ja)	2013-10-21	2017-10-11	大鵬薬品工業株式会社	新規ｃｔｌエピトープ４連結ペプチド
SG10202111399YA (en)	2015-12-22	2021-11-29	Immatics Biotechnologies Gmbh	Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
GB201522667D0 (en)	2015-12-22	2016-02-03	Immatics Biotechnologies Gmbh	Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
GB201604458D0 (en)	2016-03-16	2016-04-27	Immatics Biotechnologies Gmbh	Peptides and combination of peptides for use in immunotherapy against cancers
CA3019835A1 (en)	2016-04-08	2017-10-12	Purdue Research Foundation	Methods and compositions for car t cell therapy
CN110612119B (zh)	2017-02-07	2024-10-29	西雅图儿童医院（Dba西雅图儿童研究所）	磷脂醚(ple)car t细胞肿瘤靶向(ctct)剂
WO2018160622A1 (en)	2017-02-28	2018-09-07	Endocyte, Inc.	Compositions and methods for car t cell therapy
WO2019004415A1 (ja) *	2017-06-30	2019-01-03	国立大学法人大阪大学	末梢血ｔ細胞の腫瘍細胞傷害活性を指標とする腫瘍免疫療法の効果予測方法
EP3701952A4 (de)	2017-10-26	2021-06-30	Otsuka Pharmaceutical Co., Ltd.	Inositphosphathaltige zusammensetzung
US11311576B2 (en)	2018-01-22	2022-04-26	Seattle Children's Hospital	Methods of use for CAR T cells
CN112105382A (zh)	2018-02-23	2020-12-18	恩多塞特公司	用于car t细胞疗法的顺序方法
KR20240099456A (ko)	2018-06-29	2024-06-28	다이호야쿠힌고교 가부시키가이샤	항종양제 및 그 평가방법
EP4082563A4 (de)	2019-12-26	2024-02-28	Taiho Pharmaceutical Co., Ltd.	Mittel zur postoperativen adjuvanten therapie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5874231A (en) *	1994-08-22	1999-02-23	Mcgill University	Methods of screening for non-hormone compounds which effect modulation of polypeptide translation
US5936078A (en)	1995-12-12	1999-08-10	Kyowa Hakko Kogyo Co., Ltd.	DNA and protein for the diagnosis and treatment of Alzheimer's disease
WO1997021807A1 (fr) *	1995-12-12	1997-06-19	Kyowa Hakko Kogyo Co., Ltd.	Nouveaux adn, nouveaux polypeptides et nouveaux anticorps
US5840839A (en) *	1996-02-09	1998-11-24	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
JP2000189168A (ja) *	1998-12-28	2000-07-11	Hiroshi Handa	新規転写伸長抑制因子
WO2001012660A2 (en) *	1999-08-17	2001-02-22	Sagami Chemical Research Center	HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS

2001
- 2001-07-30 AU AU2002227498A patent/AU2002227498A1/en not_active Abandoned
- 2001-07-30 EP EP01984425A patent/EP1306431B1/de not_active Expired - Lifetime
- 2001-07-30 JP JP2002516288A patent/JP4900884B2/ja not_active Expired - Lifetime
- 2001-07-30 AT AT01984425T patent/ATE389668T1/de not_active IP Right Cessation
- 2001-07-30 WO PCT/JP2001/006526 patent/WO2002010369A1/ja active IP Right Grant
- 2001-07-30 DE DE60133287T patent/DE60133287T2/de not_active Expired - Lifetime
- 2001-07-30 ES ES01984425T patent/ES2304398T3/es not_active Expired - Lifetime
- 2001-07-30 CA CA2417570A patent/CA2417570C/en not_active Expired - Lifetime
2003
- 2003-01-30 US US10/353,929 patent/US7148326B2/en not_active Expired - Lifetime
2006
- 2006-10-05 US US11/543,088 patent/US7404270B2/en not_active Expired - Lifetime
- 2006-10-05 US US11/543,066 patent/US7408037B2/en not_active Expired - Lifetime
- 2006-10-05 US US11/543,089 patent/US7432354B2/en not_active Expired - Lifetime
- 2006-10-05 US US11/543,087 patent/US7427660B2/en not_active Expired - Lifetime
- 2006-10-05 US US11/543,065 patent/US7524930B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
US20070031433A1 (en)	2007-02-08
US7427660B2 (en)	2008-09-23
US7148326B2 (en)	2006-12-12
EP1306431B1 (de)	2008-03-19
US7404270B2 (en)	2008-07-29
US20070031431A1 (en)	2007-02-08
US7408037B2 (en)	2008-08-05
ATE389668T1 (de)	2008-04-15
AU2002227498A1 (en)	2002-02-13
US7524930B2 (en)	2009-04-28
JP4900884B2 (ja)	2012-03-21
ES2304398T3 (es)	2008-10-16
DE60133287T2 (de)	2009-03-26
EP1306431A4 (de)	2004-08-18
US20070031432A1 (en)	2007-02-08
US20070071767A1 (en)	2007-03-29
WO2002010369A1 (en)	2002-02-07
US20070066804A1 (en)	2007-03-22
CA2417570C (en)	2010-12-07
CA2417570A1 (en)	2003-01-31
US7432354B2 (en)	2008-10-07
US20030175288A1 (en)	2003-09-18
EP1306431A1 (de)	2003-05-02

Publication	Publication Date	Title
DE60133287D1 (de)	2008-04-30	Tumorantigen
GB9823897D0 (en)	1998-12-30	Immunotherapeutic methods and molecules
WO2001075067A8 (en)	2004-10-14	Novel nucleic acids and polypeptides
WO2001057188A3 (en)	2002-02-28	Novel nucleic acids and polypeptides
WO2001057190A3 (en)	2006-11-16	Novel nucleic acids and polypeptides
WO2002022660A3 (en)	2003-07-17	Novel nucleic acids and polypeptides
WO2001066689A3 (en)	2002-05-30	Novel nucleic acids and polypeptides
WO2002031111A3 (en)	2002-10-17	Novel nucleic acids and polypeptides
WO2001088088A3 (en)	2002-10-31	Novel nucleic acids and polypeptides
WO2002059260A3 (en)	2003-04-10	Nucleic acids and polypeptides
WO2001079449A3 (en)	2002-03-28	Novel nucleic acids and polypeptides
WO2002018424A3 (en)	2003-05-15	Nucleic acids and polypeptides
ATE464383T1 (de)	2010-04-15	Tumor antigen
DK1370284T3 (da)	2010-09-27	Bakteriofag-medieret immunisering
NO922421D0 (no)	1992-06-19	Collagenbindende protein, samt fremstilling derav
CY1105820T1 (el)	2011-02-02	Basb027 πρωτεϊνες και γονιδια απο moraxella catarrhalis, αντιγονα, αντισωματα και χρησεις
WO2002044340A3 (en)	2003-06-26	Novel nucleic acids and polypeptides
WO2003008450A1 (en)	2003-01-30	Tumor antigen
ATE397069T1 (de)	2008-06-15	Basb205 polypeptide und dafür kodierende polynukleotide
DE69928931D1 (de)	2006-01-19	Moraxella catarrhalis polynukleotide und polypeptide
WO2001087917A8 (en)	2007-07-19	Novel nucleic acids and polypeptides
WO2001075093A8 (en)	2002-07-25	Novel nucleic acids and polypeptides
DE60140006D1 (de)	2009-11-05	Polypeptide aus haemophilus influenza
ATE454452T1 (de)	2010-01-15	Basb118 polypeptid und polynukleotid aus moraxella catarrhalis
ATE360073T1 (de)	2007-05-15	Basb119 polypeptid und polynukleotid aus moraxella catarrhalis

Legal Events

Date	Code	Title	Description
2009-04-30	8364	No opposition during term of opposition